Synergistic anti-glioma effect of Hydroxygenkwanin and Apigenin in vitro

Chemico-Biological Interactions

Volumn 206, Issue 2, 2013, Pages 346-355

  Wang, Yi ^a   Xu, You Song ^a   Yin, Lian Hong ^a   Xu, Li Na ^a   Peng, Jin Yong ^a   Zhou, Hang ^a   Kang, Wei ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apigenin; Apoptosis; C6; Glioma; Hydroxygenkwanin; Synergistic effect

Indexed keywords

APIGENIN; CARMUSTINE; CASPASE 3; CASPASE 8; FLAVONOID; HYDROXYGENKWANIN; PROTEIN BAK; PROTEIN BCL XL; PROTEIN BID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGLIOMA EFFECT; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; DRUG POTENTIATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; RAT; S PHASE CELL CYCLE CHECKPOINT; UPREGULATION;

APIGENIN; APOPTOSIS; C6; GLIOMA; HYDROXYGENKWANIN; SYNERGISTIC EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIGENIN; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; FLAVONOIDS; FLUORESCENT DYES; GLIOMA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PC12 CELLS; RATS; S PHASE CELL CYCLE CHECKPOINTS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84886738098     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.10.009     Document Type: Article

References (43)

1. J.R. Molina, Y. Hayashi, C. Stephens, and M.M. Georgescu Invasive glioblastoma cells acquire stemness and increased Akt activation Neoplasia 12 2010 453 463
2. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, R.C. Janzer, S.K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A.A. Brandes, J. Gijtenbeek, C. Marosi, C.J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J.G. Cairncross, and R.O. Mirimanoff Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol. 10 2009 459 466
3. L.A. Stewart Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 2002 1011 1018
4. S. Agarwal, P. Manchanda, M.A. Vogelbaum, J.R. Ohlfest, and W.F. Elmquist Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in a orthotopic rat xenograft model of glioma Drug Metab. Dispos. 41 2013 33 39
5. K. Awang, M.N. Azmi, L.I. Aun, A.N. Aziz, H. Ibrahim, and N.H. Nagoor The apoptotic effect of 1′s-1′-acetoxychavicol acetate from Alpinia conchigera on human cancer cells Molecules 15 2010 8048 8059
6. C.C. Yeh, C.N. Tseng, J.I. Yang, H.W. Huang, Y. Fang, J.Y. Tang, F.R. Chang, and H.W. Chang Antiproliferation and induction of apoptosis in Ca9-22 oral cancer cells by ethanolic extract of gracilaria tenuistipitata Molecules 17 2012 10916 10927
7. L.W. Fu, Z.A. Deng, Q.C. Pan, and W. Fan Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids Anticancer Res. 21 2001 2273 2280
8. J. Sun, C.A. Yeung, N.N. Co, T.Y. Tsang, E. Yau, K. Luo, P. Wu, J.C. Wa, K.P. Fung, T.T. Kwok, and F. Liu Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-kappaB in R-HepG2 cell line PLoS One 7 2012 e40720
9. K.A. Youdim, M.Z. Qaiser, D.J. Begley, C.A. Rice-Evans, and N.J. Abbott Flavonoid permeability across an in situ model of the blood-brain barrier Free Radical Biol. Med. 36 2004 592 604
10. Deng Shiren, Xia Linbo, Dong Qian, Guo Yanhua, and Jia Tianzhu HPLC fingerprint of flos genkwa and its ESI-MS analysis Chin. J. Exp. Tradit. Med. Formulae 17 2011
11. H. Xie, Y. Liang, Y. Ito, X. Wang, R. Chen, J. He, H. Li, and T. Zhang Preparative isolation and purification of four flavonoids from Daphne genkwa Sieb. Et Zucc. By high-speed countercurrent chromatography J. Liq. Chromatogr. Relat. Technol. 34 2011 2360 2372
12. Y.N. Li, L.H. Yin, L.N. Xu, and J.Y. Peng A simple and efficient protocol for large-scale preparation of three flavonoids from the flower of Daphne genkwa by combination of macroporous resin and counter-current chromatography J. Sep. Sci. 33 2010 2168 2175
13. W. Jiang, J. Kou, Z. Zhang, and B. Yu The effects of twelve representative flavonoids on tissue factor expression in human monocytes: structure-activity relationships Thromb. Res. 124 2009 714 720
14. N. Li, J.H. Liu, J. Zhang, and B.Y. Yu Comparative evaluation of cytotoxicity and antioxidative activity of 20 flavonoids J. Agric. Food Chem. 56 2008 3876 3883
15. A. Das, N.L. Banik, and S.K. Ray Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes Cancer 116 2010 164 176
16. S. Silvan, S. Manoharan, N. Baskaran, C. Anusuya, S. Karthikeyan, and M.M. Prabhakar Chemopreventive potential of apigenin in 7,12-dimethylbenz(a) anthracene induced experimental oral carcinogenesis Eur. J. Pharmacol. 670 2011 571 577
17. H. Cheong, S.Y. Ryu, M.H. Oak, S.H. Cheon, G.S. Yoo, and K.M. Kim Studies of structure activity relationship of flavonoids for the anti-allergic actions Arch. Pharmacal. Res. 21 1998 478 480
18. D. Romanova, A. Vachalkova, L. Cipak, Z. Ovesna, and P. Rauko Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method Neoplasma 48 2001 104 107
19. J.A. Ross, and C.M. Kasum Dietary flavonoids: bioavailability, metabolic effects, and safety Annu. Rev. Nutr. 22 2002 19 34
20. J. Czyz, Z. Madeja, U. Irmer, W. Korohoda, and D.F. Hulser Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro Int. J. Cancer 114 2005 12 18
21. S. Kasibhatla, G.P. Amarante-Mendes, D. Finucane, T. Brunner, E. Bossy-Wetzel, and D.R. Green Acridine orange/ethidium Bromide (AO/EB) staining to detect apoptosis CSH Protoc. 2006 2006
22. B. Daniel, and M.A. DeCoster Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining Brain Res. Brain Res. Protoc. 13 2004 144 150
23. R.J. Youle, and A. Strasser The BCL-2 protein family: opposing activities that mediate cell death Nat. Rev. Mol. Cell Biol. 9 2008 47 59
24. Y. Xu, Y. Xin, Y. Diao, C. Lu, J. Fu, L. Luo, and Z. Yin Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells PLoS One 6 2011 e29169
25. S.H. Lee, J.K. Ryu, K.Y. Lee, S.M. Woo, J.K. Park, J.W. Yoo, Y.T. Kim, and Y.B. Yoon Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer Cancer Lett. 259 2008 39 49
26. K.F. Chan, Y. Zhao, B.A. Burkett, I.L. Wong, L.M. Chow, and T.H. Chan Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells J. Med. Chem. 49 2006 6742 6759
27. D. Arango, A. Parihar, F.A. Villamena, L. Wang, M.A. Freitas, E. Grotewold, and A.I. Doseff Apigenin induces DNA damage through the PKCdelta-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair Biochem. Pharmacol. 84 2012 1571 1580
28. T.H. Khan, T. Jahangir, L. Prasad, and S. Sultana Inhibitory effect of apigenin on benzo(a)pyrene-mediated genotoxicity in Swiss albino mice J. Pharm. Pharmacol. 58 2006 1655 1660
29. M. Marinic, I. Piantanida, G. Rusak, and M. Zinic Interactions of quercetin and its lanthane complex with double stranded DNA/RNA and single stranded RNA: spectrophotometric sensing of poly G J. Inorg. Biochem. 100 2006 288 298
30. G. Rusak, I. Piantanida, L. Masic, K. Kapuralin, K. Durgo, and N. Kopjar Spectrophotometric analysis of flavonoid-DNA interactions and DNA damaging/protecting and cytotoxic potential of flavonoids in human peripheral blood lymphocytes Chem. Biol. Interact. 188 2010 181 189
31. Y.C. Tsai, Y.H. Wang, C.C. Liou, Y.C. Lin, H. Huang, and Y.C. Liu Induction of oxidative DNA damage by flavonoids of propolis: its mechanism and implication about antioxidant capacity Chem. Res. Toxicol. 25 2012 191 196
32. I. Fukuda, R. Mukai, M. Kawase, K. Yoshida, and H. Ashida Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids Biochem. Biophys. Res. Commun. 359 2007 822 827
33. Z. Zhang, C.Z. Wang, G.J. Du, L.W. Qi, T. Calway, T.C. He, W. Du, and C.S. Yuan Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells Int. J. Oncol. 43 2013 289 296
34. S. Gupta, F. Afaq, and H. Mukhtar Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells Oncogene 21 2002 3727 3738
35. M.B. Ujiki, X.Z. Ding, M.R. Salabat, D.J. Bentrem, L. Golkar, B. Milam, M.S. Talamonti, R.H. Bell Jr., T. Iwamura, and T.E. Adrian Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest Mol. Cancer 5 2006 76
36. F. Yin, A.E. Giuliano, R.E. Law, and A.J. Van Herle Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells Anticancer Res. 21 2001 413 420
37. D.M. Lepley, B. Li, D.F. Birt, and J.C. Pelling The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes Carcinogenesis 17 1996 2367 2375
38. D.S. Goodsell The molecular perspective: tumor necrosis factor Oncologist 11 2006 83 84
39. C. Munoz-Pinedo Signaling pathways that regulate life and cell death: evolution of apoptosis in the context of self-defense Adv. Exp. Med. Biol. 738 2012 124 143
40. R. Reyes, M. Guo, K. Swann, S.U. Shetgeri, S.M. Sprague, D.F. Jimenez, C.M. Barone, and Y. Ding Role of tumor necrosis factor-alpha and matrix metalloproteinase-9 in blood-brain barrier disruption after peripheral thermal injury in rats J. Neurosurg. 110 2009 1218 1226
41. F. Takata, S. Dohgu, J. Matsumoto, H. Takahashi, T. Machida, T. Wakigawa, E. Harada, H. Miyaji, M. Koga, T. Nishioku, A. Yamauchi, and Y. Kataoka Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro J. Neuroinflamm. 8 2011 106
42. D.J. Guillaume, N.D. Doolittle, S. Gahramanov, N.A. Hedrick, J.B. Delashaw, and E.A. Neuwelt Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study Neurosurgery 66 2010 48 58 discussion 58
43. T. Nakamura, R. Saito, S. Sugiyama, Y. Sonoda, T. Kumabe, and T. Tominaga Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model Cancer Lett. 310 2011 77 83